These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8157043)

  • 1. The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis.
    Shyu WC; Pittman KA; Robinson DS; Barbhaiya RH
    Eur J Clin Pharmacol; 1993; 45(6):559-62. PubMed ID: 8157043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopharmaceutical evaluation of transnasal, sublingual, and buccal disk dosage forms of butorphanol.
    Shyu WC; Mayol RF; Pfeffer M; Pittman KA; Gammans RE; Barbhaiya RH
    Biopharm Drug Dispos; 1993 Jul; 14(5):371-9. PubMed ID: 8218955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The absolute bioavailability and pharmacokinetics of butorphanol nasal spray in patients with hepatic impairment.
    Vachharajani NN; Shyu WC; Garnett WR; Morgenthien EA; Barbhaiya RH
    Clin Pharmacol Ther; 1996 Sep; 60(3):283-94. PubMed ID: 8841151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of intranasal butorphanol administered from a single-dose sprayer.
    Davis GA; Rudy AIa; Archer SM; Wermeling DP
    Am J Health Syst Pharm; 2005 Jan; 62(1):48-53. PubMed ID: 15658072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of age and sex on the systemic availability and pharmacokinetics of transnasal butorphanol.
    Shyu WC; Morgenthien EA; Pittman KA; Barbhaiya RH
    Eur J Clin Pharmacol; 1994; 47(1):57-60. PubMed ID: 7988625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple-dose phase I study of transnasal butorphanol.
    Shyu WC; Pittman KA; Robinson D; Barbhaiya RH
    Clin Pharmacol Ther; 1993 Jul; 54(1):34-41. PubMed ID: 8330463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of butorphanol tartrate administered from single-dose intranasal sprayer.
    Davis GA; Rudy AC; Archer SM; Wermeling DP
    Am J Health Syst Pharm; 2004 Feb; 61(3):261-6. PubMed ID: 14986556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of butorphanol nasal spray in patients with renal impairment.
    Shyu WC; Morgenthien EA; Barbhaiya RH
    Br J Clin Pharmacol; 1996 May; 41(5):397-402. PubMed ID: 8735680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics comparison between subcutaneous and intravenous butorphanol administration in horses.
    Chiavaccini L; Claude AK; Lee JH; Ross MK; Meyer RE; Langston VC
    J Vet Pharmacol Ther; 2015 Aug; 38(4):365-74. PubMed ID: 25484250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of butorphanol after intravenous, intramuscular, and oral administration in Hispaniolan Amazon parrots (Amazona ventralis).
    Guzman DS; Flammer K; Paul-Murphy JR; Barker SA; Tully TN
    J Avian Med Surg; 2011 Sep; 25(3):185-91. PubMed ID: 22216718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of allergic rhinitis and its treatment on the pharmacokinetics of nasally administered fentanyl.
    Perelman M; Fisher AN; Smith A; Knight A
    Int J Clin Pharmacol Ther; 2013 May; 51(5):349-56. PubMed ID: 23458227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and intramuscular bioavailability of a single dose of butorphanol in Asian elephants (Elephas maximus).
    Tana LM; Isaza R; Koch DE; Hunter RP
    J Zoo Wildl Med; 2010 Sep; 41(3):418-25. PubMed ID: 20945638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of butorphanol in horses after intramuscular injection.
    Sellon DC; Papich MG; Palmer L; Remund B
    J Vet Pharmacol Ther; 2009 Feb; 32(1):62-5. PubMed ID: 19161457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of pharmacokinetic interaction between butorphanol tartrate nasal spray and sumatriptan succinate.
    Srinivas NR; Shyu WC; Upmalis D; Lee JS; Barbhaiya RH
    J Clin Pharmacol; 1995 Apr; 35(4):432-7. PubMed ID: 7650235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and adverse effects of butorphanol administered by single intravenous injection or continuous intravenous infusion in horses.
    Sellon DC; Monroe VL; Roberts MC; Papich MG
    Am J Vet Res; 2001 Feb; 62(2):183-9. PubMed ID: 11212025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of butorphanol tartrate in red-tailed hawks (Buteo jamaicensis) and great horned owls (Bubo virginianus).
    Riggs SM; Hawkins MG; Craigmill AL; Kass PH; Stanley SD; Taylor IT
    Am J Vet Res; 2008 May; 69(5):596-603. PubMed ID: 18447789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain management.
    Gillis JC; Benfield P; Goa KL
    Drugs; 1995 Jul; 50(1):157-75. PubMed ID: 7588085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of butorphanol in llamas after intravenous and intramuscular administration.
    Carroll GL; Boothe DM; Hartsfield SM; Martinez EA; Spann AC; Hernandez A
    J Am Vet Med Assoc; 2001 Nov; 219(9):1263-7. PubMed ID: 11697372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability and pharmacokinetics of intranasal hydromorphone in patients experiencing vasomotor rhinitis.
    Davis GA; Rudy AC; Archer SM; Wermeling DP; McNamara PJ
    Clin Drug Investig; 2004; 24(11):633-9. PubMed ID: 17523726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.